Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells extremities and biologics products. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries, as well as other ancillary products. The company primarily offers its products to orthopaedic, trauma, and podiatric surgeons. It markets and sells its products through direct sales representatives and independent sales agencies in the United States, as well as direct sales offices and distributors in approximately 50 countries. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
Phone31-20-521-4777
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$744.99 million
Profitability
Miscellaneous
Employees2,675
OptionableOptionable
Wright Medical Group (NASDAQ:WMGI) Frequently Asked Questions
What is Wright Medical Group's stock symbol?
Wright Medical Group trades on the NASDAQ under the ticker symbol "WMGI."
How often does Wright Medical Group pay dividends? What is the dividend yield for Wright Medical Group?
Wright Medical Group announced a dividend on Tuesday, December 11th. Stockholders of record on Wednesday, December 5th will be given a dividend of $1.50 per share on Monday, December 10th. The ex-dividend date of this dividend is Wednesday, December 12th. View Wright Medical Group's Dividend History.
How were Wright Medical Group's earnings last quarter?
Wright Medical Group NV (NASDAQ:WMGI) issued its quarterly earnings data on Wednesday, November, 7th. The medical device company reported ($0.09) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.06. The medical device company earned $194.11 million during the quarter, compared to analysts' expectations of $186.09 million. Wright Medical Group had a negative return on equity of 0.60% and a negative net margin of 13.07%. The company's revenue was up 13.8% on a year-over-year basis. During the same period in the previous year, the business posted ($0.16) EPS. View Wright Medical Group's Earnings History.
When is Wright Medical Group's next earnings date?
How can I listen to Wright Medical Group's earnings call?
Wright Medical Group will be holding an earnings conference call on Tuesday, February 26th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.
What guidance has Wright Medical Group issued on next quarter's earnings?
Wright Medical Group issued an update on its FY 2018 earnings guidance on Monday, January, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $836.2-836.2 million, compared to the consensus revenue estimate of $834 million.Wright Medical Group also updated its Q4 2018 guidance to EPS.
What price target have analysts set for WMGI?
15 analysts have issued 1 year price objectives for Wright Medical Group's shares. Their predictions range from $25.00 to $35.00. On average, they anticipate Wright Medical Group's stock price to reach $32.6429 in the next year. This suggests a possible upside of 14.1% from the stock's current price. View Analyst Price Targets for Wright Medical Group.
What is the consensus analysts' recommendation for Wright Medical Group?
15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Wright Medical Group in the last year. There are currently 2 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Wright Medical Group.
What are Wall Street analysts saying about Wright Medical Group stock?
Here are some recent quotes from research analysts about Wright Medical Group stock:
- 1. Needham & Company LLC analysts commented, "On 1/7/19, WMGI guided to above consensus 4Q18 preliminary revenue and provided new long-term financial targets for 2019 through 2021. Organic revenue growth slowed to 10% (adjusting for selling days) in 4Q18 from 14% in 3Q18. Strong US Lower Extremities growth was slightly offset by a slowdown in the US Upper Extremities business though we note that US Upper Extremities faced its toughest comp of the year. And WMGI announced two management changes that we think may be CEO succession planning. While we currently model ~11% organic growth in 2019, we expect Cartiva, a stronger US Lower Extremities sales force, and recently launched products to drive upside to consensus and we reiterate our Buy rating." (1/7/2019)
- 2. Cantor Fitzgerald analysts commented, "We reiterate our Overweight rating and a 12-month price target of $35 on shares of WMGI. We think WMGI is positioned to outperform expectations in 2018 with multiple drivers across each of its three primary segments (lower extremities, upper extremities, and biologics) to accelerate growth. We see WMGI’s valuation as attractive, as we expect innovative products to help WMGI to capitalize on the evolving market trends. Valuation Summary We base our $35 price target on a ~5.5x EV/Sales multiple on our 2019 sales estimate." (12/10/2018)
Has Wright Medical Group been receiving favorable news coverage?
Press coverage about WMGI stock has trended very positive on Tuesday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Wright Medical Group earned a daily sentiment score of 3.2 on InfoTrie's scale. They also assigned media headlines about the medical device company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.
Who are some of Wright Medical Group's key competitors?
Some companies that are related to Wright Medical Group include Steris (STE), WILLIAM DEMANT/ADR (WILYY), MSA Safety (MSA), Inogen (INGN), Avanos Medical (AVNS), Establishment Labs (ESTA), Sientra (SIEN), RTI Surgical (RTIX), Invacare (IVC), Lakeland Industries (LAKE), ConforMIS (CFMS), Bionik Laboratories (BNKL), COLLPLANT HOLDI/S (CLGN), NanoVibronix (NAOV) and Precision Therapeutics (AIPT).
Who are Wright Medical Group's key executives?
Wright Medical Group's management team includes the folowing people:
- Mr. Robert J. Palmisano, Pres, CEO & Exec. Director (Age 73)
- Mr. Lance A. Berry, Sr. VP & CFO (Age 46)
- Mr. James A. Lightman, Sr. VP, Gen. Counsel & Sec. (Age 60)
- Mr. Jason D. Asper, Sr. VP of Strategy & Corp. Devel. (Age 43)
- Mr. Kevin D. Cordell, Pres of U.S. (Age 52)
Who are Wright Medical Group's major shareholders?
Wright Medical Group's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Peregrine Capital Management LLC (0.76%), Sit Investment Associates Inc. (0.03%), Toth Financial Advisory Corp (0.02%) and Bank of Montreal Can (0.00%). Company insiders that own Wright Medical Group stock include David D Stevens, Elizabeth H Weatherman, Gregory Morrison, James Lightman, Jennifer S Walker, John L Miclot, Jonathan Wesley Porter, Julie Andrews, Kevin C Oboyle, Kevin D Cordell, Lance A Berry, Patrick Fisher, Peter Cooke, Richard F Wallman and Robert P Burrows III. View Institutional Ownership Trends for Wright Medical Group.
Which institutional investors are selling Wright Medical Group stock?
WMGI stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC. Company insiders that have sold Wright Medical Group company stock in the last year include Elizabeth H Weatherman, James Lightman, Jennifer S Walker, Julie Andrews, Kevin C Oboyle, Kevin D Cordell, Lance A Berry, Patrick Fisher, Peter Cooke and Robert P Burrows III. View Insider Buying and Selling for Wright Medical Group.
Which institutional investors are buying Wright Medical Group stock?
How do I buy shares of Wright Medical Group?
Shares of WMGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Wright Medical Group's stock price today?
One share of WMGI stock can currently be purchased for approximately $28.60.
How big of a company is Wright Medical Group?
Wright Medical Group has a market capitalization of $3.58 billion and generates $744.99 million in revenue each year. The medical device company earns $-202,590,000.00 in net income (profit) each year or ($0.22) on an earnings per share basis. Wright Medical Group employs 2,675 workers across the globe.
What is Wright Medical Group's official website?
How can I contact Wright Medical Group?
Wright Medical Group's mailing address is PRINS BERNHARDPLEIN 200, AMSTERDAM P7, 1097 JB. The medical device company can be reached via phone at 31-20-521-4777 or via email at [email protected]
MarketBeat Community Rating for Wright Medical Group (NASDAQ WMGI)
MarketBeat's community ratings are surveys of what our community members think about Wright Medical Group and other stocks. Vote "Outperform" if you believe WMGI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WMGI will underperform the S&P 500 over the long term. You may vote once every thirty days.
